0
By clicking the button, I accept the Terms of Use of the service and its Privacy Policy, as well as consent to the processing of personal data.
Don’t have an account? Signup
Powered by :
Mankind Pharma gets CDSCO approval to start Phase 1 trial of MKP11093, an oral JAK-1 inhibitor for autoimmune disorders including arthritis and colitis.
Share this article
If you liked this article share it with your friends.they will thank you later